MERCORELLI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.681
AS - Asia 1.641
EU - Europa 1.061
SA - Sud America 353
AF - Africa 348
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 20
Totale 7.138
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.483
SG - Singapore 586
CN - Cina 429
IT - Italia 233
BR - Brasile 231
HK - Hong Kong 152
DE - Germania 131
VN - Vietnam 106
FI - Finlandia 97
RU - Federazione Russa 62
PL - Polonia 53
SE - Svezia 53
NL - Olanda 43
FR - Francia 42
GB - Regno Unito 41
KR - Corea 41
UA - Ucraina 36
AR - Argentina 30
IN - India 27
AT - Austria 23
CA - Canada 21
CI - Costa d'Avorio 21
ID - Indonesia 19
IL - Israele 19
IE - Irlanda 18
CZ - Repubblica Ceca 15
MX - Messico 15
TR - Turchia 15
ZA - Sudafrica 15
JP - Giappone 14
PY - Paraguay 14
RE - Reunion 14
GH - Ghana 13
HR - Croazia 13
LB - Libano 13
LU - Lussemburgo 13
NC - Nuova Caledonia 13
NI - Nicaragua 13
SK - Slovacchia (Repubblica Slovacca) 13
CD - Congo 12
CW - ???statistics.table.value.countryCode.CW??? 12
EG - Egitto 12
HT - Haiti 12
KG - Kirghizistan 12
MA - Marocco 12
MY - Malesia 12
UY - Uruguay 12
AZ - Azerbaigian 11
BS - Bahamas 11
ET - Etiopia 11
GR - Grecia 11
GT - Guatemala 11
HU - Ungheria 11
IS - Islanda 11
KE - Kenya 11
MR - Mauritania 11
MU - Mauritius 11
MZ - Mozambico 11
SA - Arabia Saudita 11
SN - Senegal 11
AM - Armenia 10
BE - Belgio 10
BO - Bolivia 10
BW - Botswana 10
BZ - Belize 10
CL - Cile 10
CU - Cuba 10
DK - Danimarca 10
EC - Ecuador 10
ES - Italia 10
GA - Gabon 10
GF - Guiana Francese 10
JO - Giordania 10
ML - Mali 10
PA - Panama 10
PR - Porto Rico 10
RS - Serbia 10
VE - Venezuela 10
AO - Angola 9
BF - Burkina Faso 9
CH - Svizzera 9
CR - Costa Rica 9
DJ - Gibuti 9
DO - Repubblica Dominicana 9
GP - Guadalupe 9
IR - Iran 9
JM - Giamaica 9
KZ - Kazakistan 9
LY - Libia 9
MD - Moldavia 9
PE - Perù 9
PK - Pakistan 9
TN - Tunisia 9
TW - Taiwan 9
TZ - Tanzania 9
UZ - Uzbekistan 9
AL - Albania 8
BB - Barbados 8
BG - Bulgaria 8
BY - Bielorussia 8
Totale 6.803
Salva come PNG Salva come JPEG
Città #
Fairfield 515
Ashburn 392
Singapore 353
Woodbridge 264
Chandler 232
Houston 228
Cambridge 195
Seattle 194
Ann Arbor 190
Hong Kong 148
Wilmington 144
Beijing 142
Santa Clara 97
Boardman 69
Helsinki 54
San Diego 51
Jacksonville 47
Princeton 43
Hefei 42
Los Angeles 42
Munich 37
Bytom 35
Ho Chi Minh City 35
Seoul 32
Roxbury 31
Guangzhou 28
Medford 28
Padova 27
Dearborn 25
New York 23
Columbus 22
Abidjan 21
São Paulo 21
Des Moines 20
Nanjing 20
Hanoi 19
Council Bluffs 18
Shanghai 17
Frankfurt am Main 16
Buffalo 15
Dong Ket 15
Dublin 15
Rome 14
Accra 13
Brooklyn 13
Chicago 13
Managua 13
Milan 13
Noumea 13
Johannesburg 12
Shenyang 12
Baku 11
Dakar 11
Kinshasa 11
Maputo 11
Nassau 11
Nouakchott 11
Perugia 11
Willemstad 11
Amman 10
Havana 10
Naples 10
Nuremberg 10
Pune 10
Redondo Beach 10
Vienna 10
Yerevan 10
Bamako 9
Bishkek 9
Boston 9
Gaborone 9
Lappeenranta 9
Libreville 9
London 9
Montevideo 9
Panama City 9
San José 9
Turku 9
Warsaw 9
Addis Ababa 8
Bridgetown 8
Castries 8
Cayenne 8
Dar es Salaam 8
Elk Grove Village 8
Kharkiv 8
Kigali 8
Nairobi 8
Niamey 8
Phnom Penh 8
Salt Lake City 8
San Donà di Piave 8
Ulan Bator 8
Berlin 7
Chisinau 7
Conakry 7
Djibouti 7
Luanda 7
Lusaka 7
Norwalk 7
Totale 4.515
Salva come PNG Salva come JPEG
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 303
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 233
Antiviral strategies against influenza virus: towards new therapeutic approaches. 230
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 221
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 218
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 214
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. 214
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 206
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. 203
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 201
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 196
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. 190
The 6-Aminoquinolone WC5 Inhibits Human Cytomegalovirus Replication at an Early Stage by Interfering with the Transactivating Activity of Viral Immediate-Early 2 Protein 189
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 189
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 184
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 182
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity 178
A point mutation in a herpesvirus polymerase determines neuropathogenicity. 178
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein. 176
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 173
The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 is Modified by SUMO in a DNA-dependent manner 166
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 164
The 6-Aminoquinolone WC5 Inhibits Different Functions of the Immediate-Early 2 (IE2) Protein of Human Cytomegalovirus That Are Essential for Viral Replication. 159
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 158
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism 156
Human cytomegalovirus DNA replication: antiviral targets and drugs. 148
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication 146
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 143
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 140
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 138
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 137
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 136
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses. 134
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 133
Sulfated Derivatives of Escherichia coli K5 Polysaccharide are Potent Inhibitors of Human Cytomegalovirus. 133
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 131
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 129
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 116
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 106
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 97
Caratterizzazione di nuovi composti antivirali contro il citomegalovirus umano e studio del meccanismo di neuropatogenocità nel herpesvirus equino di tipo 1 96
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 88
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches 86
Composition and methods for the treatment of pathological condition associated with cytomegalovirus infection. 65
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer 31
Antiviral drug repurposing: different approaches and the case of antifungal drugs 27
Totale 7.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.399
article - articoli 21.212
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 242
selected - selezionate 0
volume - volumi 564
Totale 44.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021405 0 0 0 0 19 24 26 41 75 36 77 107
2021/2022589 10 70 90 51 47 29 34 64 13 18 59 104
2022/2023510 86 55 22 48 91 64 4 40 49 17 32 2
2023/2024388 7 51 62 26 40 33 45 27 8 32 25 32
2024/20251.388 5 156 72 47 153 52 97 102 86 70 205 343
2025/20262.351 290 395 634 787 245 0 0 0 0 0 0 0
Totale 7.241